홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Methyl morpholine oxide → HCID 178519309, 화합물

HRID 1061560
인쇄

반응식

HRID 1061560 반응식
[F:1][C:2]1[CH:3]=[C:4]([C:9](=[O:30])[C:10](=[C:19]2[NH:23][C:22]3[CH:24]=[CH:25][C:26]([CH2:28][OH:29])=[CH:27][C:21]=3[NH:20]2)[C:11]([C:13]2[CH:18]=[CH:17][CH:16]=[CH:15][CH:14]=2)=[O:12])[CH:5]=[C:6]([F:8])[CH:7]=1.C[N+]1([O-])CCOCC1>CCC[N+](CCC)(CCC)CCC.[O-][Ru](=O)(=O)=O.ClCCl>[F:1][C:2]1[CH:3]=[C:4]([CH:5]=[C:6]([F:8])[CH:7]=1)[C:9]([C:10](=[C:19]1[NH:23][C:22]2[CH:24]=[CH:25][C:26]([CH:28]=[O:29])=[CH:27][C:21]=2[NH:20]1)[C:11](=[O:12])[C:13]1[CH:18]=[CH:17][CH:16]=[CH:15][CH:14]=1)=[O:30]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 2

HCID 82029Methyl morpholine oxideHCID 178520873HCID 178520873, 화합물

생성물 1

HCID 178519309HCID 178519309, 화합물수율 44%

시약·촉매·용매 2

HCID 178419074HCID 178419074, 화합물촉매HCID 6344Dichloromethane용매

실험 절차

Into a dichloromethane solution (5 ml) of the compound (174 mg) obtained in Example 405 were added NMO (100 mg) and MS4A, followed by 10 minutes of stirring at room temperature. TPAP (8 mg) was further added thereto, followed by 30 minutes of stirring at room temperature. The reaction solution was purified by silica gel column chromatography (eluent: chloroform:methanol=40:1 (v/v)) to obtain 2-[1-(3,5-difluorobenzoyl)-2-oxo-2-phenylethylidene]-2,3-dihydro-1H-benzimidazol-5-carbaldehyde (76 mg, 44%).

후처리

  1. waitfollowed by 30 minutes
  2. stirringof stirring at room temperature
  3. customThe reaction solution was purified by silica gel column chromatography (eluent: chloroform:methanol=40:1 (v/v))

출처 및 근거

ORD 기록
ord-8c4b3d50771d464ea3b69a46aed2824d
출처 데이터셋
uspto-grants-2005_11
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06960591B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트